The impact of the economic crisis on the availability of essential medicines in 83 countries

被引：0
|
作者：
Hogerzeil, H. V. [1 ]
Laing, R. [1 ]
机构：
[1] World Hlth Org, Geneva, Switzerland
来源：
TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2009年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [31] The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries
    Mendis, Shanthi
    Fukino, Keiko
    Cameron, Alexandra
    Laing, Richard
    Filipe, Antonio, Jr.
    Khatib, Oussama
    Leowski, Jerzy
    Ewen, Margaret
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2007, 85 (04) : 279 - 288
  • [32] Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
    Husain, Muhammad Jami
    Datta, Biplab Kumar
    Kostova, Deliana
    Joseph, Kristy T.
    Asma, Samira
    Richter, Patricia
    Jaffe, Marc G.
    Kishore, Sandeep P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (09):
  • [33] The availability of essential medicines for cardiovascular diseases in low- and middle-income countries: A case study of Bangladesh
    Uddin, Md Jamal
    Hakim, Shariful
    Chowdhury, Muhammad Abdul Baker
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 174 - 174
  • [34] The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries
    Zaheer-Ud-Din Babar
    Charon Lessing
    Cécile Mace
    Karen Bissell
    PharmacoEconomics, 2013, 31 : 1063 - 1082
  • [35] The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries
    Babar, Zaheer-Ud-Din
    Lessing, Charon
    Mace, Cecile
    Bissell, Karen
    PHARMACOECONOMICS, 2013, 31 (11) : 1063 - 1082
  • [36] The Impact Of The Global Financial And Economic Crisis On The Convergence Process In OECD Countries
    Greta, Marianna
    Lewandowski, Krzysztof
    COMPARATIVE ECONOMIC RESEARCH-CENTRAL AND EASTERN EUROPE, 2015, 18 (01): : 81 - 96
  • [37] REVIEW OF ECONOMIC EVIDENCE ON THE IMPACT OF SUBSTANDARD AND FALSIFIED MEDICINES IN LOW AND MIDDLE INCOME COUNTRIES
    Ozawa, S.
    Bessias, S.
    Haynie, D.
    Yemeke, T.
    Herrington, J.
    VALUE IN HEALTH, 2017, 20 (05) : A19 - A20
  • [38] Availability and accessibility of cytotoxic medicines in the WHO model list of essential medicines for childhood cancer in low and lower-middle- income countries: a systematic review
    Seneviwickrama, Maheeka
    Denagamagei, Sashini Shehana
    Jayakody, Surangi
    Gunasekera, Sanjeeva
    Liyanage, Guwani
    BMC CANCER, 2025, 25 (01)
  • [39] Medicines availability at a Swaziland hospital and impact on patients
    Shabangu, Kholiwe
    Suleman, Fatima
    AFRICAN JOURNAL OF PRIMARY HEALTH CARE & FAMILY MEDICINE, 2015, 7 (01)
  • [40] Commentary: The pros and cons of essential medicines for rich countries
    Reidenberg, MM
    Walley, T
    BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7475): : 1172 - 1172
12345